Goldman Sachs’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Goldman Sachs’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-212,900	Closed	-$36.8M	–	7689
2015 Q1	$36.8M	Buy	212,900 +160,900	+309%	+$23.6M	0.01%	1320
2014 Q4	$5.98M	Sell	52,000 -377,600	-88%	-$45.7M	﹤0.01%	2825
2014 Q3	$67.1M	Buy	429,600 +399,600	+1,332%	+$57.9M	0.02%	866
2014 Q2	$3.7M	Buy	+30,000	New	+$3.32M	﹤0.01%	3350

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Goldman Sachs's SLXP Position: Q2 2015 in Review

Goldman Sachs sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,733,556 shares — an estimated $300M sold.

Goldman Sachs first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $300M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Goldman Sachs reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Goldman Sachs sold 1,733,556 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $300M.
Goldman Sachs first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Goldman Sachs's SALIX PHARMACEUTICALS LTD DEL position peaked at $300M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.